CTS
CTS Corporation
CTS's fundamentals are strong: it turned 19% of its revenue into free cash flow and free cash flow grew 35%. At 24x earnings, it's trading right at its usual valuation. Analysts expect earnings growth.
CTS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
CTS's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
CTS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $61.01 | — |
| Cheap | 22x | $54.94 | -10% |
| Current | 24x | $61.01 | — |
| Fair | 25x | $62.16 | +1.9% |
| Expensive | 29x | $73.78 | +21% |
Historical ranges are pointers, not guarantees.
CTS's PE is in its fair range at 24x. If earnings grow as analysts expect, today's price would be 21x next year's earnings, in its cheap range.
CTS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CTS, with profitability improving.
CTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.85 | +13% |
| Q3 2026 | $2.53 | +29% |
| Q2 2026 | $2.38 | +13% |
| Q1 2026 | $2.34 | +19% |
| Q4 2025 | $2.19 | +16% |
| Q3 2025 | $1.96 | +1% |
| Q2 2025 | $2.11 | +19% |
| Q1 2025 | $1.97 | +16% |
| Q4 2024 | $1.89 | -1.6% |
CTS earned $2.53 per share over the past year, up 29% from the year before.
CTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $149.6M | +4.6% |
| Q2 2026 | $144.8M | +7% |
| Q1 2026 | $139.2M | +11% |
| Q4 2025 | $137.3M | +7.7% |
| Q3 2025 | $143M | +8% |
| Q2 2025 | $135.3M | +4% |
| Q1 2025 | $125.8M | 0% |
| Q4 2024 | $127.4M | +2.2% |
CTS's revenue has grown year over year for eight quarters in a row: $150M last quarter, up 4.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +2.4 points |
| Q2 2026 | 19% | +1.7 points |
| Q1 2026 | 16% | +2.8 points |
| Q4 2025 | 17% | +1.6 points |
| Q3 2025 | 15% | -1.6 points |
| Q2 2025 | 17% | +3.2 points |
| Q1 2025 | 13% | +1.4 points |
| Q4 2024 | 15% | +1.9 points |
CTS's operating margin was 17% last quarter, up 2.4 points from the same quarter a year ago.
CTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $41.1M | +70% |
| Q2 2026 | $28.9M | +15% |
| Q1 2026 | $12.3M | +11% |
| Q4 2025 | $26M | +31% |
| Q3 2025 | $24.2M | -23% |
| Q2 2025 | $25.1M | +67% |
| Q1 2025 | $11.1M | -23% |
| Q4 2024 | $19.9M | -31% |
CTS's free cash flow has been positive every quarter for seven years: $108M over the past year, up 35% from the year before.
CTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +8K shares |
| 1 year | -2.4% | -710K shares |
| 3 years | -8.2% | -2.6M shares |
| 5 years | -11% | -3.5M shares |
| Available history | -13% | -4.2M shares |
CTS has 29M diluted shares, down 2.4% from a year ago, with $32M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.3M |
| Q2 2026 | $3.4M |
| Q1 2026 | $8.6M |
| Q4 2025 | $16.6M |
| Q3 2025 | $16.6M |
| Q2 2025 | $16.5M |
| Q1 2025 | $6.5M |
| Q4 2024 | $7.8M |
CTS spent $32M buying back its own shares over the past year, down 33% from the year before.
CTS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Net Cash |
| Q4 2024 | -0.0x | Net Cash |
CTS has more cash than debt.
CTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 49.7 | Neutral |
CTS's weekly RSI is 54 (neutral) and its Stochastic is 50 (neutral).
CTS PE vs Technology Sector
| Metric | CTS | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 28x | 13% below |
| PE % | 43 | 35 | 8 pts above |
CTS is trading at 24x earnings, a 13% discount to the Technology sector's median of 28x.
CTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $58.3 | 4.6% above |
| 20 week MA | $59.4 | 2.7% above |
| 50 week MA | $55.8 | 9.3% above |
| 100 week MA | $49.4 | 24% above |
| 200 week MA | $47.6 | 28% above |
CTS is in an uptrend: it's above all five of its weekly moving averages, and 28% above its 200-week average.
CTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.6 | $33.7 | +14% |
| 2021 | $33.7 | $36.3 | +7.8% |
| 2022 | $36.3 | $38.9 | +7.1% |
| 2023 | $38.9 | $43.7 | +12% |
| 2024 | $43.7 | $53.1 | +21% |
| 2025 | $53.1 | $44.5 | -16% |
| 2026 YTD | $44.5 | $61.0 | +37% |
CTS has finished higher in five of the last six years. It's up 37% so far in 2026.